Neuroimaging endpoints in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative, clinically heterogeneous syndrome pathologically overlapping with frontotemporal dementia. To date, therapeutic trials in animal models have not been able to predict treatment response in humans, and the revised Amyotrophic Late...
Auteurs principaux: | Menke, R, Agosta, F, Grosskreutz, J, Filippi, M, Turner, M |
---|---|
Format: | Journal article |
Publié: |
Springer Verlag
2016
|
Documents similaires
-
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.
par: Turner, M, et autres
Publié: (2011) -
Neuroimaging in amyotrophic lateral sclerosis.
par: Turner, M, et autres
Publié: (2012) -
Basal ganglia alterations in amyotrophic lateral sclerosis
par: Veronica Castelnovo, et autres
Publié: (2023-04-01) -
The tough body at the epicentre of amyotrophic lateral sclerosis
par: Turner, M, et autres
Publié: (2017) -
Structural and functional neuroimaging in amyotrophic lateral sclerosis
par: Ilya S. Bakulin, et autres
Publié: (2017-08-01)